Novoray Corp
SSE:688300
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
30.61
69.76
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Novoray Corp
Capital Expenditures
Novoray Corp
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Novoray Corp
SSE:688300
|
Capital Expenditures
-¥53m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Juhua Co Ltd
SSE:600160
|
Capital Expenditures
-¥3.2B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
|
|
Hengli Petrochemical Co Ltd
SSE:600346
|
Capital Expenditures
-¥25.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-78%
|
|
|
Satellite Chemical Co Ltd
SZSE:002648
|
Capital Expenditures
-¥3.1B
|
CAGR 3-Years
22%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-9%
|
|
|
Jiangsu Eastern Shenghong Co Ltd
SZSE:000301
|
Capital Expenditures
-¥15B
|
CAGR 3-Years
26%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-85%
|
|
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
Capital Expenditures
-¥35.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-28%
|
|
Novoray Corp
Glance View
In the bustling landscape of modern technology companies, Novoray Corp has carved out a niche with its cutting-edge solutions in the realm of imaging and radiography technology. Founded by a group of visionary engineers and entrepreneurs, Novoray emerged from the need to innovate within medical and industrial sectors. The company has honed its expertise in developing advanced imaging systems that harness the power of digital radiography and computed tomography. These systems find applications in diverse fields ranging from healthcare diagnostics to industrial non-destructive testing, offering unparalleled clarity and precision. Novoray's commitment to research and development is evident in its consistently innovative product lineup, attracting a loyal clientele composed of hospitals, manufacturing units, and research institutions worldwide. At the heart of Novoray's business model lies its multi-faceted revenue streams. The company generates income by selling state-of-the-art imaging equipment, complemented by service contracts for maintenance and upgrades, ensuring clients have continuous access to the latest technology. Beyond hardware sales, Novoray has strategically boosted its recurring revenue through software solutions that enhance image processing and diagnostics. This software-as-a-service (SaaS) approach facilitates smooth integration into clients' existing systems, driving efficiency and improving outcomes. Additionally, Novoray capitalizes on training and consultancy services, empowering clients to leverage their technology to its full potential. Through these various avenues, Novoray Corp not only sustains its financial health but also secures a reputation as a leader in precision imaging solutions.
See Also
What is Novoray Corp's Capital Expenditures?
Capital Expenditures
-53m
CNY
Based on the financial report for Dec 31, 2023, Novoray Corp's Capital Expenditures amounts to -53m CNY.
What is Novoray Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-16%
Over the last year, the Capital Expenditures growth was 66%. The average annual Capital Expenditures growth rates for Novoray Corp have been 25% over the past three years , -16% over the past five years .
You don't have any saved screeners yet
